Curology Receives $15M Series B Investment Led by Advance Vixeid Partners

Curology, a direct-to-consumer prescription dermatology company, received $15M to use to scale their business to reach more consumers. The funding is led by Advance Vixeid Partners, with participation from Sherpa Capital and Forerunner Ventures, two prior investors.

Curology was founded by dermatologist David Lortscher, MD. Patients submit pictures of their skin issues, which licensed medical professionals evaluate based on the company’s platform and prescribe a topical solution. Private equity companies have been interested in dermatology, which is a difficult-to-access specialty for patients. Curology uses telemedicine and a direct-to-consumer model, also hot segments for investment.